Hepatocellular carcinoma: New and emerging risks

被引:22
|
作者
Sherman, Morris [1 ,2 ]
机构
[1] Univ Toronto, Dept Med, Toronto, ON M5N 2N2, Canada
[2] Univ Hlth Network, Toronto, ON M5N 2N2, Canada
关键词
Cirrhosis; Hepatitis B; Hepatitis C; Hepatocellular carcinoma;
D O I
10.1016/S1590-8658(10)60508-7
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The underlying liver diseases that put patients at risk for the development of hepatocellular carcinoma (HCC) are well known. However, it is equally well known that not all patients with these conditions will develop HCC. Therefore within the disease groups (hepatitis B, cirrhosis, etc.,) there are other factors that indicate greater or lesser risk. Some markers of risk are common to all causes of HCC, such as cellular dysplasia, advancing age and male gender. Others factors are specific to individual diseases. This has been well established for hepatitis B in which viral load, genotype and antigen status are major contributors to increased risk of HCC. For both hepatitis B and hepatitis C attempts have been made to identify those individuals at greatest risk using data from large cohort studies. In addition to the common causes of liver disease that are recognized to be causes of HCC non-alcoholic fatty liver disease and possibly diabetes are newly emerging risk factors. (C) 2010 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:S215 / S222
页数:8
相关论文
共 50 条
  • [1] Known, new and emerging risk factors of hepatocellular carcinoma
    Trad, Dorra
    Bibani, Norsaf
    Sabbah, Meriam
    Elloumi, Hela
    Gargouri, Dalila
    Ouakaa, Asma
    Kharrat, Jamel
    PRESSE MEDICALE, 2017, 46 (11): : 1000 - 1007
  • [2] Emerging approaches in hepatocellular carcinoma
    Kulik, Laura M.
    Mulcahy, Mary F.
    Omary, Reed A.
    Salem, Riad
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2007, 41 (09) : 839 - 854
  • [3] Thalassemia and hepatocellular carcinoma: links and risks
    Marsella, Maria
    Ricchi, Paolo
    JOURNAL OF BLOOD MEDICINE, 2019, 10 : 323 - 334
  • [4] Emerging agents and regimens for hepatocellular carcinoma
    Zhu, Xiao-Dong
    Sun, Hui-Chuan
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (01)
  • [5] Emerging Therapeutic Approaches to Hepatocellular Carcinoma
    Pawlik, Timothy M.
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (05) : 1217 - 1218
  • [6] Emerging Signaling Pathways in Hepatocellular Carcinoma
    Moeini, Agrin
    Cornella, Helena
    Villanueva, Augusto
    LIVER CANCER, 2012, 1 (02) : 83 - 93
  • [7] Emerging drugs for the treatment of hepatocellular carcinoma
    Ayoub, Walid S.
    Jones, Patricia D.
    Yang, Ju Dong
    Martin, Paul
    EXPERT OPINION ON EMERGING DRUGS, 2022, 27 (02) : 141 - 149
  • [8] Emerging therapies in advanced hepatocellular carcinoma
    Medavaram, Sowmini
    Zhang, Yue
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2018, 7
  • [9] Emerging therapies in advanced hepatocellular carcinoma
    Sowmini Medavaram
    Yue Zhang
    Experimental Hematology & Oncology, 7
  • [10] Emerging Therapies for Hepatocellular Carcinoma (HCC)
    Chakraborty, Eesha
    Sarkar, Devanand
    CANCERS, 2022, 14 (11)